Truist lifts Boston Scientific stock target to $120, maintains Buy
Truist Securities expressed a positive outlook on Boston Scientific (NYSE:BSX) shares, raising the price target to $120 from $110, while reaffirming a Buy rating. The stock, currently trading near its ...
Truist raises TTM Technologies stock target to $38, maintains Buy
Truist Securities adjusted its outlook on TTM Technologies (NASDAQ:TTMI), a leading global printed circuit board (PCB) manufacturer, by increasing the price target to $38.00, up from the previous $32.